Putnam Investments LLC Chemo Centryx, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $918,501 - $4.87 Million	-95,777 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $473,704 - $654,177	9,564 Added 11.09%	95,777 $4.91 Million
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $647,608 - $893,082	13,706 Added 18.9%	86,213 $5.34 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $2.37 Million - $3.15 Million	51,082 Added 238.42%	72,507 $3.97 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $826,576 - $1.39 Million	21,425 New	21,425 $1.23 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.